Example: Heart Attack

Search clinical trials for: Insulin aspart

Total 559 results

NCT04184466

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

Conditions: Clamp Study
NCT04414579

Recruiting

The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus

Conditions: Type 1 Diabetes Mellitus
NCT03450863

Completed

Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

Conditions: Diabetes; Diabetes Mellitus, Type 1 Diabetes
NCT04772729

Not yet recruiting

Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

Conditions: Diabetes type1; Diabetes Mellitus, Type 1
NCT04237129

Completed

PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males

Conditions: Diabetes Mellitus, Type 1
NCT02462161

Completed

Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart

Conditions: Alzheimer's Disease; Mild Cognitive Impairment
NCT04620967

Recruiting

Fast-Acting Insulin Aspart and Insulin Pump Settings

Conditions: Type 1 Diabetes
NCT03407599

Completed

A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

Conditions: Diabetes; Diabetes Mellitus, Type 1
NCT00969592

Completed

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Conditions: Diabetes
NCT03554486

Completed

Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy

Conditions: Diabetes Mellitus, Type 1
NCT01474538

Completed

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Conditions: Type 2 Diabetes Mellitus
NCT02491528

Unknown status

A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

Conditions: Diabetes
NCT00428207

Terminated

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

Conditions: Type 1 Diabetes Mellitus
NCT03816761

Completed

Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1
NCT04184492

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

Conditions: Clamp Study
NCT01399346

Completed

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT04660305

Recruiting

AT278 and NovoRapid® in Glucose Clamp Study

Conditions: Diabetes Mellitus, Type 1
NCT03579615

Recruiting

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

Conditions: Diabetes Mellitus, Type 1
NCT01159353

Completed

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Conditions: Type 2 Diabetes Mellitus
NCT03977727

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Conditions: Type 1 Diabetes Mellitus
NCT01293396

Completed

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

Conditions: Type 2 Diabetes
NCT04079413

Completed

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Conditions: Diabetes; Diabetes Mellitus, Type 1
NCT01510093

Completed

Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)

Conditions: Type 2 Diabetes Mellitus
NCT03959514

Completed

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Conditions: Diabetes Mellitus, Type 1
NCT01487369

Completed

Special Survey of Production of Insulin Aspart Specific Antibody

Conditions: Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2